MRI scans not catching all high grade prostate tumors

Jodelle Maglaya | | Health Imaging | Cardiac Imaging

According to investigators who reported their fidings at the Society of Urologic Oncology's 17th annual meeting, standard 12-core prostate biopsies need to be given regardless if there were no findings of prostate lesions on MRI scans.

Researchers found that in their study, 13 percent of high grade prostate tumors were not seen on a prostate MRI and later revealed by transrectal ultrasound (TRUS) 12-core biopsy. 

Lead investigator Eric Kim, MD and his colleagues at Washington University School of Medicine in St. Louis studied 84 men with negative prostate MRI who then underwent standard TRUS prostate biopsy. 

See results here:

Standard TRUS Prostate Biopsy Needed Despite Negative MRIs

Jodelle Maglaya

Jodelle joined TriMed Media Group in 2016 as a senior writer, focusing on content for Radiology Business and Health Imaging. After receiving her master's from DePaul University, she worked as a news reporter and communications specialist.

Related Content

AI-enhanced echocardiography improves early detection of cardiac amyloidosis
AI-enabled coronary plaque evaluations included in new RBM guidelines
ASE shares new recommendations for evaluating LV diastolic function, HFpEF
AI enables tracking of coronary artery calcium growth on routine lung cancer CT scans
AI turns low-quality MRI scans into helpful heart images
Cardiologists, radiologists and surgeons share ‘landmark’ document on assessing prosthetic heart valves with CT

Around the web

Cardiovascular Business
AI-enabled coronary plaque evaluations included in new RBM guidelines

The use of advanced AI software to assess CCTA images continues to gain more momentum.

Cardiovascular Business
ASE shares new recommendations for evaluating LV diastolic function, HFpEF

The new guidelines detail the use of echocardiography to evaluate patients for a variety of conditions.

Health Exec
Major association of physicians presents itself as a go-to alternative vs. the government on vaccine expertise

One of the most formidable societies of medical professionals in the U.S. is going toe-to-toe with Robert F. Kennedy’s HHS over changing vaccination recommendations.